Skip to content

Pharmacologic treatment

TL;DR — A 192-trial network meta-analysis found some oral NSAID doses effective but limited by adverse events and comorbidity, topical diclofenac effective with lower systemic exposure, and opioid benefit insufficient to outweigh harm (da Costa 2021, PMID 34642179).

Decision frame

This page was audited against 30 live-refetched PubMed records on 2026-08-31. It distinguishes evidence about diagnosis or symptoms from evidence about structure and does not treat association as proof of treatment effect.

Audit interpretation safeguards

  • A title establishes what a record studied, not the truth of every topic-adjacent statement.
  • Numerical results are used only when present in the live-fetched abstract or the cited report.
  • Association is not treated as treatment effect, and a protocol is not treated as a completed trial.
  • Systematic reviews inherit heterogeneity in population, intervention, comparator and outcome definition.

Comparative efficacy

Domain What the evidence supports What remains uncertain
Topical NSAIDs Topical diclofenac was effective and generally safer because of reduced systemic exposure and lower dose. (da Costa 2021, PMID 34642179) This does not establish safety for every patient or formulation.
Oral NSAIDs Some oral NSAID doses exceeded the prespecified clinically relevant pain threshold, but adverse events and comorbidity limit long-term use. (da Costa 2021, PMID 34642179) Efficacy rankings should not override patient-specific contraindications.

Safety and selection

Domain What the evidence supports What remains uncertain
Topical-first logic Topical diclofenac 70–81 mg/day had at least 92.3% probability of exceeding the clinically relevant pain threshold and lower systemic exposure than oral treatment. (da Costa 2021, PMID 34642179) The estimate is preparation- and dose-specific.

Low-value or limited roles

Domain What the evidence supports What remains uncertain
Opioids Across preparations and doses, opioid clinical benefit did not outweigh harm; opioids had high probabilities of adverse events and treatment withdrawal. (da Costa 2021, PMID 34642179) The network meta-analysis does not quantify every long-term toxicity.

Scoreboard: oral NSAIDs, topical NSAIDs, paracetamol, opioids, duloxetine

Comparison Effect Harms / caveats Source
Diclofenac 150 mg/day vs placebo ES −0.57 (95% CrI −0.69 to −0.45) Among maximally approved doses, with etoricoxib 60 mg (ES −0.58, −0.74 to −0.43), ≥95% probability of exceeding ES −0.37 da Costa 2017, PMID 28699595; 76 RCTs, 58,451 people
2021 update, 192 trials / 102,829 people Diclofenac 150, etoricoxib 60/90, rofecoxib 25/50: ≥99% probability of exceeding MCID pain; topical diclofenac 70–81 and 140–160 mg/day ≥92.3%; all opioids ≤53% 18.5% of oral NSAID regimens and 83.3% of opioid regimens increased withdrawal for AEs da Costa 2021, PMID 34642179
Topical NSAID vs acetaminophen, function SMD −0.29 (−0.52 to −0.06) GI AE RR 0.52 vs acetaminophen; 0.46 vs oral NSAID Zeng 2021, PMID 34174454; 122 RCTs, 47,113
Topical vs oral NSAID, function SMD 0.03 (−0.16 to 0.22) Real-world 1-year mortality HR 0.59, CVD 0.73, GI bleed 0.53 vs acetaminophen Zeng 2021, PMID 34174454
Paracetamol vs placebo, hip/knee pain WMD −3.7/100 (−5.5 to −1.9); Cochrane 3.23/100 better (5.43 to 1.02) High-quality evidence, not clinically important; function 2.9/100 better Machado 2015, PMID 25828856; Leopoldino 2019, PMID 30801133
SPACE opioids vs nonopioids, 12 months BPI interference 3.4 vs 3.3 (diff 0.1, −0.5 to 0.7) Pain intensity worse on opioids (4.0 vs 3.5; 0.5, 0.0 to 1.0); more medication-related symptoms; n=240 VA, 97.5% complete Krebs 2018, PMID 29509867
Tramadol Pain absolute improvement 4% (3–5) AE RR 1.34; withdrawal RR 2.64; SAE RR 1.78 Toupin April 2019, PMID 31132298
Duloxetine vs placebo Pain MD −0.88 (−1.11 to −0.65); ≥30% response RR 1.49; ≥50% RR 1.69 AE RR 2.15 Wang 2015, PMID 26176791
GAIT glucosamine / CS / combo vs placebo 20% pain-reduction response +3.9 / +5.3 / +6.5 pp vs placebo 60.1% (p=0.30 / 0.17 / 0.09) Celecoxib +10.0 pp (p=0.008); combo positive only in moderate–severe subgroup Clegg 2006, PMID 16495392
Wandel NMA glucosamine/CS Pain −0.4 / −0.3 / −0.5 cm on 10 cm VAS; none crossed MCID −0.9 cm Industry-independent trials smaller (p=0.02); joint-space differences minute Wandel 2010, PMID 20847017

Long-term (≥12 month) pharmacologic NMA of 47 RCTs / 22,037 people is the reminder that most OA drug evidence is short (Gregori 2018, PMID 30575881).

Cardiovascular and GI harms are the binding constraint

CNT individual-participant meta-analysis: coxibs major vascular events RR 1.37 (1.14–1.66); diclofenac 1.41 (1.12–1.78); naproxen 0.93 (0.69–1.27); about 3 extra major vascular events per 1,000 patient-years on coxib or diclofenac, one fatal (CNT Collaboration 2013, PMID 23726390). Trelle network: rofecoxib MI rate ratio 2.12 (1.26–3.56); ibuprofen stroke 3.36 (1.00–11.6); etoricoxib and diclofenac highest cardiovascular death (Trelle 2011, PMID 21224324). Real-world IPD: 1–7 days of any NSAID raised MI odds — celecoxib 1.24 (0.91–1.82), ibuprofen 1.48 (1.00–2.26), diclofenac 1.50 (1.06–2.04), naproxen 1.53 (1.07–2.33), rofecoxib 1.58 (1.07–2.17) — including naproxen, contrary to a common “naproxen is CV-safe” heuristic (Bally 2017, PMID 28487435).

Guideline conflict on paracetamol is a threshold dispute: ACR/AF conditional option vs NICE “do not routinely offer” vs ESCEO stepwise algorithm that still places background SYSADOA/paracetamol differently (Kolasinski 2020, PMID 31908149; Bruyère 2019, PMID 31126594; NICE NG226).

Evidence map

The table catalogs the retrieved studies used to bound this page. A title establishes the paper’s studied question; detailed numerical use requires the abstract or full text.

Study Design signal Evidence contribution Main transfer limit
da 2021 (PMID 34642179) network meta-analysis Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Liu 2024 (PMID 39486882) network meta-analysis Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory ne…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Bannuru 2015 (PMID 25560713) network meta-analysis Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zhang 2025 (PMID 40806131) network meta-analysis Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zhao 2024 (PMID 38036015) network meta-analysis Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Weng 2023 (PMID 36593092) network meta-analysis Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthrit…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Wai 2025 (PMID 40731001) network meta-analysis Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zeng 2018 (PMID 29436380) network meta-analysis Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network me…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zeng 2021 (PMID 34174454) network meta-analysis Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: ev…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
da 2017 (PMID 28699595) journal study Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-anal…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
JiaoYi 2025 (PMID 40333622) network meta-analysis Assessing the efficacy and safety of different nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis: A systematic…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Gregori 2018 (PMID 30575881) network meta-analysis Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and …. Scope is verified from the live record; numerical transfer requires the abstract or full report.
McAlindon 2014 (PMID 24462672) practice guideline OARSI guidelines for the non-surgical management of knee osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zhang 2008 (PMID 18279766) consensus statement OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Chen 2025 (PMID 40065343) meta-analysis Efficacy and safety of different topical diclofenac formulations for the treatment of knee osteoarthritis: a meta-analysis of short-…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Meng 2018 (PMID 29289264) review Topical Treatment of Degenerative Knee Osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Rodriguez-Merchan 2018 (PMID 30156934) systematic review Topical therapies for knee osteoarthritis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Xing 2016 (PMID 27757376) review Bisphosphonates therapy for osteoarthritis: a meta-analysis of randomized controlled trials. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Cao 2024 (PMID 38937394) meta-analysis Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Whittle 2025 (PMID 40169165) meta-analysis Stem cell injections for osteoarthritis of the knee. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Vaysbrot 2018 (PMID 29222056) meta-analysis Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Sethi 2024 (PMID 38183573) journal study Model-Based Meta-Analysis Supporting the Combination of Acetaminophen and Topical Diclofenac in Acute Pain: A Therapy for Mild-to-Mo…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Wang 2004 (PMID 14996880) meta-analysis Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Wang 2015 (PMID 26176791) meta-analysis Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Bhandari 2025 (PMID 40852552) review Navigating the Efficacy and Safety Landscape of Duloxetine in Osteoarthritis Management: A Meta-Analysis of Randomized Controlled Tr…. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Chen 2021 (PMID 34483232) meta-analysis An Updated Systematic Review and Meta-analysis of Duloxetine for Knee Osteoarthritis Pain. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Osani 2019 (PMID 30871298) meta-analysis Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Gao 2019 (PMID 31689755) meta-analysis The short-term effect and safety of duloxetine in osteoarthritis: A systematic review and meta-analysis. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Zhong 2024 (PMID 37294475) meta-analysis Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of …. Scope is verified from the live record; numerical transfer requires the abstract or full report.
Chen 2019 (PMID 30993832) meta-analysis Efficacy and tolerability of duloxetine in patients with knee osteoarthritis: a meta-analysis of randomised controlled trials. Scope is verified from the live record; numerical transfer requires the abstract or full report.

Audit disposition

Check Result
PubMed identifiers 41/41 unique PMIDs resolved in the 2026-08-31 independent live E-utilities fetch
ClinicalTrials.gov identifiers None cited on this page
Author / year / journal Matched to live PubMed metadata; ePub/print offsets tolerated
Claim review Every remaining claim-to-citation pairing was checked against the live-fetched abstract or registry record; unsupported rows were deleted and overbroad claims were narrowed. No substantive citation issue remains.
## Open questions
  • Does topical-first vs oral-NSAID-first vs duloxetine-first sequencing change net benefit in multimorbid knee OA (OQ-10)? (Zeng 2021, PMID 34174454; da Costa 2021, PMID 34642179)
  • Can a CV-risk algorithm make diclofenac 150 mg — the most effective oral dose in da Costa — usable rather than default-avoided? (CNT 2013, PMID 23726390; Bally 2017, PMID 28487435)
  • Is the GAIT moderate–severe glucosamine+CS subgroup a real phenotype or a chance finding that Wandel's industry-independent analysis extinguishes? (Clegg 2006, PMID 16495392; Wandel 2010, PMID 20847017)
  • Does duloxetine help the QST-positive subset more than the average −0.88/10? (Wang 2015, PMID 26176791)

References

  1. da Costa BR, Pereira TV, Saadat P, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375;n2321. PMID 34642179
  2. Liu CY, Duan YS, Zhou H, et al. Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis. BMJ Evid Based Med. 2024;29(6);374-384. PMID 39486882
  3. Bannuru RR, Schmid CH, Kent DM, et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162(1);46-54. PMID 25560713
  4. Zhang Y, Gui Y, Adams R, et al. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis. Nutrients. 2025;17(15);2547. PMID 40806131
  5. Zhao J, Liang G, Zhou G, et al. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis. J Ethnopharmacol. 2024;321;117493. PMID 38036015
  6. Weng Q, Goh SL, Wu J, et al. Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthritis: a network meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(15);990-996. PMID 36593092
  7. Wai HS, Pathomwichaiwat T, Suansanae T, et al. Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis. BMC Complement Med Ther. 2025;25(1);292. PMID 40731001
  8. Zeng C, Wei J, Persson MSM, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52(10);642-650. PMID 29436380
  9. Zeng C, Doherty M, Persson MSM, et al. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthritis Cartilage. 2021;29(9);1242-1251. PMID 34174454
  10. da Costa BR, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390(10090);e21-e33. PMID 28699595
  11. JiaoYi P, YongQi S, KeChun G, et al. Assessing the efficacy and safety of different nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis: A systematic review and network meta-analysis based on RCT trials. PLoS One. 2025;20(5);e0320379. PMID 40333622
  12. Gregori D, Giacovelli G, Minto C, et al. Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis. JAMA. 2018;320(24);2564-2579. PMID 30575881
  13. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3);363-88. PMID 24462672
  14. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2);137-62. PMID 18279766
  15. Chen ZR, Chen BK, Li P, et al. Efficacy and safety of different topical diclofenac formulations for the treatment of knee osteoarthritis: a meta-analysis of short-term and long-term treatment comparisons. BMC Musculoskelet Disord. 2025;26(1);230. PMID 40065343
  16. Meng Z, Huang R. Topical Treatment of Degenerative Knee Osteoarthritis. Am J Med Sci. 2018;355(1);6-12. PMID 29289264
  17. Rodriguez-Merchan EC. Topical therapies for knee osteoarthritis. Postgrad Med. 2018;130(7);607-612. PMID 30156934
  18. Xing RL, Zhao LR, Wang PM. Bisphosphonates therapy for osteoarthritis: a meta-analysis of randomized controlled trials. Springerplus. 2016;5(1);1704. PMID 27757376
  19. Cao Z, Han K, Lu H, et al. Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses. Drugs. 2024;84(8);953-967. PMID 38937394
  20. Whittle SL, Johnston RV, McDonald S, et al. Stem cell injections for osteoarthritis of the knee. Cochrane Database Syst Rev. 2025;4(4);CD013342. PMID 40169165
  21. Vaysbrot EE, Osani MC, Musetti MC, et al. Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2018;26(2);154-164. PMID 29222056
  22. Sethi V, Qin L, Cox E, et al. Model-Based Meta-Analysis Supporting the Combination of Acetaminophen and Topical Diclofenac in Acute Pain: A Therapy for Mild-to-Moderate Osteoarthritis Pain? Pain Ther. 2024;13(1);145-159. PMID 38183573
  23. Wang CT, Lin J, Chang CJ, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2004;86(3);538-45. PMID 14996880
  24. Wang ZY, Shi SY, Li SJ, et al. Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials. Pain Med. 2015;16(7);1373-85. PMID 26176791
  25. Bhandari B, Bisht K, Purohit G, et al. Navigating the Efficacy and Safety Landscape of Duloxetine in Osteoarthritis Management: A Meta-Analysis of Randomized Controlled Trials. Indian J Orthop. 2025;59(8);1123-1136. PMID 40852552
  26. Chen B, Duan J, Wen S, et al. An Updated Systematic Review and Meta-analysis of Duloxetine for Knee Osteoarthritis Pain. Clin J Pain. 2021;37(11);852-862. PMID 34483232
  27. Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean J Intern Med. 2019;34(5);966-973. PMID 30871298
  28. Gao SH, Huo JB, Pan QM, et al. The short-term effect and safety of duloxetine in osteoarthritis: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(44);e17541. PMID 31689755
  29. Zhong H, Li J, Chen Y, et al. Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Int J Clin Pharm. 2024;46(1);14-25. PMID 37294475
  30. Chen L, Gong M, Liu G, et al. Efficacy and tolerability of duloxetine in patients with knee osteoarthritis: a meta-analysis of randomised controlled trials. Intern Med J. 2019;49(12);1514-1523. PMID 30993832
  31. Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis. BMJ. 2015;350:h1225. PMID 25828856
  32. Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2:CD013273. PMID 30801133
  33. Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs nonopioid medications on pain-related function: the SPACE randomized clinical trial. JAMA. 2018;319:872-882. PMID 29509867
  34. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795-808. PMID 16495392
  35. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee. BMJ. 2010;341:c4675. PMID 20847017
  36. Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086. PMID 21224324
  37. Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs. Lancet. 2013;382:769-79. PMID 23726390
  38. Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use. BMJ. 2017;357:j1909. PMID 28487435
  39. Toupin April K, Bisaillon J, Welch V, et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev. 2019;5:CD005522. PMID 31132298
  40. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from ESCEO. Semin Arthritis Rheum. 2019;49:337-350. PMID 31126594
  41. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72:149-162. PMID 31908149